|
WO2021072083A1
|
|
Na/K-ATPase LIGANDS AND USE THEREOF FOR TREATMENT OF CANCER
|
|
US2021022940A1
|
|
Knee extender devices and related methods
|
|
WO2020232263A1
|
|
Methods for treatment of obesity, atherosclerosis, and thrombosis
|
|
WO2020160464A1
|
|
Transient receptor potential melastatin 8 (trpm8) antagonists and related methods
|
|
US2019365722A1
|
|
Compositions and methods for treatment of lung infections
|
|
US2021010096A1
|
|
Bacterial cultures and methods for production of alginate
|
|
CA3074643A1
|
|
Methods for detecting na/k-atpase-mediated src signaling for diagnosis and prognosis of cancer
|
|
EP3630149A1
|
|
EXPRESSION VECTORS AND RELATED METHODS OF DELIVERY OF Na/K ATPASE/Src RECEPTOR COMPLEX ANTAGONISTS
|
|
US2020165299A1
|
|
Compositions and methods for treating pulmonary hypertension
|
|
US2018104276A1
|
|
Compositions and methods for treating striated muscle injury, treating striated muscle atrophy and/or for promoting striated muscle growth
|
|
WO2018005990A2
|
|
Compositions and methods for treating uremic cardiomyopathy
|
|
CN108697772A
|
|
Composition for treating retinopathy and method
|
|
EP3126378A1
|
|
Cardiotonic steroid antagonists and related methods
|
